At a glance
- Originator Servier
- Class Anti-ischaemics
- Mechanism of Action Antioxidants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Reperfusion injury
Most Recent Events
- 20 Apr 2001 New profile
- 12 Apr 2001 Preclinical development for Reperfusion injury in France (Unknown route)